Pharmaceuticals: Global Industry Almanac, MarketLine

NEW YORK, Aug. 23, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0911723/Pharmaceuticals-Global-Industry-Almanac-MarketLine.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceu

Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Covers the Global, European and Asia-Pacific markets as well as individual chapters on Australia, Belgium, Brazil, Canada, China, Czech Republic, Denmark, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Norway, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, United Kingdom and United States.

* Includes a five-year forecast of the industry

The global pharmaceuticals market grew by 3.6% in 2010 to reach a value of $733,104.8 million.

In 2015, the global pharmaceuticals market is forecast to have a value of $981,050.8 million, an increase of 33.8% since 2010.

Americas accounts for 44.6% of the global pharmaceuticals market value.

Pfizer is the leading player in the global pharmaceuticals market, generating a 9.4% share of the market's value.

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs for in-patient and out-patient usage, valued at ex-manufacturer prices.TABLE OF CONTENTSEXECUTIVE SUMMARY 2Market value 2Market value forecast 2Geography segmentation 2Market share 2

13What is this report about? 13Who is the target reader? 13How to use this report 13Definitions 13Global Pharmaceuticals 14Market Overview 14Market Data 15Market Segmentation 16Market outlook 18Five forces analysis 19Leading companies 27Pharmaceuticals in Asia-Pacific 38Market Overview 38Market Data 39Market Segmentation 40Market outlook 42Five forces analysis 43Leading companies 51Pharmaceuticals in Europe 60Market Overview 60Market Data 61Market Segmentation 62Market outlook 64Five forces analysis 65Leading companies 73Pharmaceuticals in France 84Market Overview 84Market Data 85Market Segmentation 86Market outlook 88Five forces analysis 89Leading companies 97Macroeconomic indicators 108Pharmaceuticals in Germany 110Market Overview 110Market Data 111Market Segmentation 112Market outlook 114Five forces analysis 115Leading companies 123Macroeconomic indicators 133Pharmaceuticals in Australia 135Market Overview 135Market Data 136Market Segmentation 137Market outlook 139Five forces analysis 140Leading companies 148Macroeconomic indicators 159Pharmaceuticals in Belgium 161Market Overview 161Market Data 162Market Segmentation 163Market outlook 165Five forces analysis 166Leading companies 174Macroeconomic indicators 185Pharmaceuticals in Brazil 187Market Overview 187Market Data 188Market Segmentation 189Market outlook 191Five forces analysis 192Leading companies 199Macroeconomic indicators 207Pharmaceuticals in Canada 209Market Overview 209Market Data 210Market Segmentation 211Market outlook 213Five forces analysis 214Leading companies 222Macroeconomic indicators 232Pharmaceuticals in China 234Market Overview 234Market Data 235Market Segmentation 236Market outlook 238Five forces analysis 239Leading companies 247Macroeconomic indicators 255Pharmaceuticals in The Czech Republic 257Market Overview 257Market Data 258Market Segmentation 259Market outlook 261Five forces analysis 262Leading companies 270Macroeconomic indicators 280Pharmaceuticals in Denmark 282Market Overview 282Market Data 283Market Segmentation 284Market outlook 286Five forces analysis 287Leading companies 295Macroeconomic indicators 305Pharmaceuticals in Hungary 307Market Overview 307Market Data 308Market Segmentation 309Market outlook 311Five forces analysis 312Leading companies 320Macroeconomic indicators 329Pharmaceuticals in India 331Market Overview 331Market Data 332Market Segmentation 333Market outlook 335Five forces analysis 336Leading companies 344Macroeconomic indicators 352Pharmaceuticals in Italy 354Market Overview 354Market Data 355Market Segmentation 356Market outlook 358Five forces analysis 359Leading companies 366Macroeconomic indicators 376Pharmaceuticals in Japan 378Market Overview 378Market Data 379Market Segmentation 380Market outlook 382Five forces analysis 383Leading companies 391Macroeconomic indicators 400Pharmaceuticals in Mexico 402Market Overview 402Market Data 403Market Segmentation 404Market outlook 406Five forces analysis 407Leading companies 415Macroeconomic indicators 425Pharmaceuticals in The Netherlands 427Market Overview 427Market Data 428Market Segmentation 429Market outlook 431Five forces analysis 432Leading companies 440Macroeconomic indicators 451Pharmaceuticals in Norway 453Market Overview 453Market Data 454Market Segmentation 455Market outlook 457Five forces analysis 458Leading companies 466Macroeconomic indicators 477Pharmaceuticals in Poland 479Market Overview 479Market Data 480Market Segmentation 481Market outlook 483Five forces analysis 484Leading companies 492Macroeconomic indicators 502Pharmaceuticals in Russia 504Market Overview 504Market Data 505Market Segmentation 506Market outlook 508Five forces analysis 509Leading companies 517Macroeconomic indicators 525Pharmaceuticals in Singapore 527Market Overview 527Market Data 528Market Segmentation 529Market outlook 531Five forces analysis 532Leading companies 540Macroeconomic indicators 550Pharmaceuticals in South Africa 552Market Overview 552Market Data 553Market Segmentation 554Market outlook 555Five forces analysis 556Leading companies 564Macroeconomic indicators 572Pharmaceuticals in South Korea 574Market Overview 574Market Data 575Market Segmentation 576Market outlook 578Five forces analysis 579Leading companies 587Macroeconomic indicators 596Pharmaceuticals in Spain 598Market Overview 598Market Data 599Market Segmentation 600Market outlook 602Five forces analysis 603Leading companies 611Macroeconomic indicators 621Pharmaceuticals in Sweden 623Market Overview 623Market Data 624Market Segmentation 625Market outlook 627Five forces analysis 628Leading companies 636Macroeconomic indicators 646Pharmaceuticals in The United Kingdom 648Market Overview 648Market Data 649Market Segmentation 650Market outlook 652Five forces analysis 653Leading companies 661Macroeconomic indicators 672Pharmaceuticals in The United States 674Market Overview 674Market Data 675Market Segmentation 676Market outlook 678Five forces analysis 679Leading companies 687Macroeconomic indicators 700Appendix 702Methodology 702

More  

Check our  

Industry Analysis and Insights

Nicolas Bombourg

Reportlinker

Email: [email protected]

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker